Browsing Tag
Kashiv BioSciences
1 post
Kashiv BioSciences bets on Latin America with Cristália deal for Xolair biosimilar
Kashiv BioSciences partners with Brazil’s Cristália to commercialize omalizumab biosimilar ADL-018 in Latin America, targeting a $140M market opportunity.